D-dimer
D-dimer is a breakdown product of a blood clot — a test with exceptionally high sensitivity for ruling out deep vein thrombosis and pulmonary embolism, but low specificity, so on its own it almost never confirms a diagnosis.
Number of studies
1
Safety
Requires caution
Time to effects
Not applicable — the D-dimer test is a diagnostic test, not an intervention.
Who it's for
Table of contents
TL;DR
D-dimer is a breakdown product of a blood clot — a test with exceptionally high sensitivity for ruling out deep vein thrombosis and pulmonary embolism, but low specificity, so on its own it almost never confirms a diagnosis.
- →Safely rules out deep vein thrombosis and pulmonary embolism in patients with low or intermediate clinical probability, without needing imaging
- →A fast, non-invasive, and widely available test in acute settings
- →Supports decisions about stopping long-term anticoagulation after an unprovoked venous thromboembolic event
| Test type | A blood test measuring a breakdown product of cross-linked fibrin, a marker of clotting and fibrinolysis |
|---|---|
| Level of evidence | Strong — high sensitivity and negative predictive value for ruling out venous thromboembolic disease |
| Target group | Patients with symptoms suggesting deep vein thrombosis or pulmonary embolism, assessed clinically |
| Key parameter | D-dimer concentration, usually in ng/mL FEU; interpreted together with clinical probability (e.g., the Wells score) |
| Preparation | Doesn't require fasting; the result is always interpreted in clinical context, never in isolation |
| Status | A test with high sensitivity but low specificity — used mainly to rule out, not confirm, a diagnosis |
Understand
Overview
D-dimer is a fragment produced when cross-linked fibrin — the protein that forms the main structural material of a blood clot — is broken down (fibrinolysis). Its presence in the blood indicates that clotting and subsequent clot dissolution have both occurred somewhere in the body, which is why this test is primarily a tool for ruling out, rather than confirming, venous thromboembolic disease — deep vein thrombosis and pulmonary embolism.
The key feature of D-dimer is its high sensitivity paired with low specificity: a normal (low) result in a patient with low or intermediate clinical probability of a clot essentially rules out that diagnosis without needing imaging. An elevated result, however, doesn't automatically mean a clot — D-dimer also rises in many other, far more common situations: after surgery, during pregnancy, in older age, with infections, inflammation, cancer, or liver or kidney failure.
Who can genuinely benefit from this? Primarily as part of a diagnostic algorithm for patients with symptoms suggesting deep vein thrombosis (swelling, calf pain) or pulmonary embolism (shortness of breath, chest pain), always combined with an assessment of clinical probability (e.g., the Wells score) — never as a standalone screening test in people without symptoms.
Mechanism of action
The blood clotting process ends with soluble fibrinogen being converted into insoluble fibrin, which forms the mesh-like scaffold of a clot, further stabilized by cross-links introduced by factor XIIIa. When the body activates its natural clot-dissolving mechanism (fibrinolysis), the enzyme plasmin breaks down this cross-linked fibrin into smaller fragments — one of which is the D-dimer, whose presence in the blood is therefore indirect evidence that a cross-linked clot formed somewhere in the body and has begun to dissolve.
Because both clotting and fibrinolysis are activated in many physiological and pathological situations — not just venous thrombosis, but also any tissue injury, surgery, childbirth, infection, or cancer — D-dimer levels rise nonspecifically in a wide range of conditions. This nonspecificity is exactly why the test works best as a rule-out tool: the absence of elevated D-dimer means no clotting-and-fibrinolysis process significant enough to explain thrombosis-like symptoms is currently active in the body.
Formation of cross-linked fibrin
Fibrinogen is converted into fibrin, stabilized by factor XIIIa cross-links, forming the clot's scaffold.
Fibrin breakdown by plasmin
Natural fibrinolysis breaks down cross-linked fibrin into fragments, including D-dimers, released into the bloodstream.
Nonspecific elevation in many conditions
Because clotting and fibrinolysis also accompany surgery, pregnancy, infection, or cancer, an elevated result has many possible causes beyond thrombosis.
Evidence: strong — based on 1 study in this database.
Benefits
Common myths
MythAn elevated D-dimer result means you have a blood clot or pulmonary embolism.
FactD-dimer has low specificity — it also rises after surgery, during pregnancy, with infections, inflammation, cancer, or simply with age, so an elevated result alone confirms nothing and requires further workup.
MythA normal D-dimer result always completely rules out a clot.
FactA negative result has high rule-out value mainly in patients with low or intermediate clinical probability of disease — with high clinical probability, further imaging is often needed regardless of the result.
Check your profile
Not sure which supplements actually make sense for you?
Answer a few short questions about your lifestyle, diet, sleep, and goals. VitMode will build your profile and show supplements worth considering — with reasoning and evidence strength.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
No — D-dimer has low specificity and also rises after surgery, during pregnancy, with infections, inflammation, cancer, or simply with age. An elevated result needs to be interpreted in clinical context and often requires further imaging.
No, the D-dimer test doesn't require fasting and can be done at any time of day, especially urgently when a clot or pulmonary embolism is suspected.
The Wells score assesses the clinical probability of a clot based on symptoms and risk factors — only combined with that assessment does the D-dimer result (especially a negative one) gain its full diagnostic value for safely ruling out disease.
What to combine with
Good combinations
Complete Blood Count (CBC) — A complete blood count helps assess the overall clinical context (e.g., signs of infection or anemia) accompanying elevated D-dimer
CRP and hs-CRP — CRP helps distinguish whether elevated D-dimer is more likely driven by active inflammation or infection rather than a clot itself
Safety
Side effects & contraindications
Possible side effects
Contraindications
No significant contraindications at typical doses.
Interactions
Pregnancy, recent surgery, trauma, childbirth, and older age physiologically raise D-dimer independent of any clot
Infections, acute inflammation, cancer, and liver or kidney failure can significantly raise the result
Anticoagulant treatment started before the blood draw can lower the result and reduce the test's sensitivity for detecting a fresh clot
Is it worth taking?
Who it's for
- People with symptoms suggesting deep vein thrombosis (calf swelling, pain, redness) or pulmonary embolism (sudden shortness of breath, chest pain)
- Patients assessed with a clinical probability score (e.g., the Wells score), where a negative result avoids unnecessary imaging
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
D-dimer has high sensitivity (around 95%) but low specificity (around 35%) for venous thromboembolic disease — which is why it's used mainly to rule out, not confirm, a diagnosis.
In patients over 50, some labs use an age-adjusted cutoff (age × 10 ng/mL FEU) to reduce false positives linked to the natural rise in D-dimer with age.
Studies
D-dimer tests are widely used in clinical practice to rule out a diagnosis of deep vein thrombosis or pulmonary embolism, but over-reliance on D-dimer in isolation should be avoided.
Linkins LA, Takach Lapner S, International Journal of Laboratory Hematology, 2017
Review of D-dimer testing: Good, Bad, and Ugly
Strong evidenceLinkins LA, Takach Lapner S · International Journal of Laboratory Hematology · 2017
A clinical review discussing the strengths and weaknesses of D-dimer testing in diagnosing venous thromboembolic disease, including causes of false-positive results and principles of correct interpretation.
View studySources & bibliography
The PubMed identifiers in this knowledge base were checked against NCBI records (October 2026). If you spot an error in a source, please let us know via the contact form.
Compare with similar entries
About the authors of this entry
Author
Redakcja VitMode — Hormony i endokrynologiaEditorial team
VitMode Editorial — Hormones and Endocrinology is the VitMode editorial team responsible for: hormones, testosterone therapy, the thyroid and metabolism. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
328 publications on this site
Editorial review
Redakcja VitMode — Serce i układ krążeniaEditorial team
VitMode Editorial — Heart and Circulation is the VitMode editorial team responsible for: the heart, blood pressure, lipids and cardiovascular prevention. The team has no individual bylines — texts are prepared by VitMode editors from primary sources (clinical trials, meta-analyses, guidelines). Every cited PubMed paper is automatically checked for a matching identifier, title and publication year. The content is educational and does not replace medical advice. Factual errors can be reported in a comment under the post or through the contact form; corrections are made by the editorial team.
75 publications on this site
Related entries
Complete Blood Count (CBC)
The most commonly ordered laboratory test in the world — a seemingly simple printout hides information about immunity, oxygen transport, and blood clotting, if you know what to look for.
CRP and hs-CRP
A protein produced by the liver in response to inflammation — in its high-sensitivity form (hs-CRP) it has become one of the most widely studied additional markers of cardiovascular risk.
How to Read a Basic Blood Test Panel
CBC, lipid panel, glucose, TSH — how to read the results of a basic blood panel so you catch early signals of a problem before it becomes a disease.
Liver Panel (ALT, AST, GGT, Bilirubin)
Four entries on a lab printout — ALT, AST, GGT, and bilirubin — can reveal liver damage before any symptoms appear, as long as you know how to tell a hepatocellular pattern apart from a cholestatic one.
Creatinine and eGFR (Estimated Glomerular Filtration Rate)
Creatinine alone tells you surprisingly little about kidney function — only converting it into eGFR using the CKD-EPI equation reveals how much filtration capacity actually remains.
TSH and Thyroid Hormones (fT3, fT4, anti-TPO)
TSH is the first-line test for evaluating thyroid function, but on its own it rarely gives the full picture — only together with fT4, fT3, and anti-TPO can it distinguish a temporary fluctuation from an actual disorder.
Electrolytes: Sodium, Potassium, and Chloride
Sodium, potassium, and chloride sound like a chemistry-class topic, but their blood levels determine how your heart, muscles, and kidneys function — and even a small deviation can be an urgent warning sign.
Uric Acid (Blood Test)
Uric acid is the end product of purine breakdown — its blood test helps assess the risk of gout and kidney stones, but a single result on its own neither confirms nor rules out disease.
Related articles
PoradnikiFlavonoids (Diosmin) and Chronic Venous Insufficiency — What Does the Meta-Analysis Show?
That feeling of heavy, swollen legs by the end of the day, nighttime calf cramps, sometimes visible varicose veins — chronic venous insufficiency affects a huge share of the adult population, especially people who stand or sit for a living. A large meta-analysis of 7 randomized trials with nearly 1,700 patients looked at how these symptoms respond to a micronized purified flavonoid fraction (MPFF, diosmin) — and found one of the lowest NNTs you'll ever see in supplement research.
August 26, 2026
PoradnikiNormal Testosterone, But You Feel Awful — Could You Still Have Hypogonadism?
A testosterone result that comes back "in range" on a lab printout doesn't always mean everything is hormonally fine — but it doesn't automatically mean you have hypogonadism either. We explain four real explanations for this mismatch, ranked by strength of evidence.
August 15, 2026
PoradnikiTRT or Natural Testosterone Boosting? A Practical Decision Test Before You Pick a Path
Before weighing the merits of TRT against the merits of lifestyle change, work out which of four situations you're actually in — because that, not preference or opinions from the internet, is what should decide your path.
August 15, 2026
PoradnikiTRT and High Estradiol — Symptoms, Causes, and What You Can Do About It
Suspect you have high estradiol on TRT? Before you reach for a forum post and someone else's anastrozole protocol, check which symptoms actually point to it and what order to act in — from bloodwork, through talking to your doctor, to a possible medication.
August 15, 2026
PoradnikiThe Most Common TRT Mistakes — 15 Things That Can Undermine Your Therapy's Results
A wrap-up of our entire testosterone therapy series: fifteen common, real mistakes — from diagnostics to discontinuation — that can turn a well-designed TRT protocol into a source of disappointment or genuine health risk.
August 15, 2026